AI Insight
Mayo Clinic researchers have launched a first-of-its-kind clinical trial investigating whether low-dose radiation therapy can slow Parkinson's disease progression by reducing inflammation in affected brain regions. The study focuses on patients with early-stage Parkinson's disease and represents a novel approach to treatment by targeting neuroinflammation rather than symptoms alone. This trial explores radiation therapy's potential anti-inflammatory properties at doses lower than those typically used in cancer treatment.
Why it matters
If successful, this approach could offer a new disease-modifying treatment for Parkinson's disease, potentially slowing its progression rather than merely managing symptoms. The trial may open new avenues for treating neurodegenerative diseases by repurposing established radiation therapy techniques for anti-inflammatory purposes.
Understand the Science
Mayo Clinic researchers are studying whether low-dose radiation therapy can slow the progression of Parkinson’s disease by targeting inflammation in areas of the brain affected by the disease. The clinical trial is the first to investigate low-dose radiation as an anti-inflammatory approach in patients with early-stage Parkinson’s disease.
Source: First-of-its-kind trial tests low-dose radiation to target brain inflammation in Parkinson's disease